Brainsway Deep TMS Therapy - for Brain Disorder Treatment

A Double Blind Randomized Controlled Evaluation of the HBLPADD-coil Transcranial Magnetic Stimulation (TMS) Device - Efficacy and Safety in Subjects with ADHD

Shalvata Mental Health Center, Israel

06 March 2013

The purpose of the study is to explore the efficacy and safety of HBLPADD Coil Deep TMS in subjects with ADHD. The Patient Population is 40 patients diagnosed with ADHD. The patients will be of all racial, ethnic and gender categories, ranging from 18 to 65 years of age.

The Structure of The study is a randomized, prospective, 5 weeks, double blind study. The treatment administrator and the study personnel and patients will be masked to the treatment being administrated. The study group will receive active Deep TMS treatment and the control group will receive an inactive, sham treatment.

The Primary Outcome Measure is will be examined by the change in the CAARS questionnaire from the baseline visit to the termination visit in the treatment group compared to the control group.

Contact:

Yaara Krueger
yaarakr@post.tau.ac.il
 
Daphna Fenchel
fenchel@post.tau.ac.il
 
Noah Aaron
noahaa@post.tau.ac.il
 
Tel: 972-9-7478644

Principal Investigator: Prof. Hilik Levkovitz


© Brainsway Ltd.® 2014 | All rights reserved. Patients Portal · Brainsway Deep TMS · FDA Clearance · Disclaimer · Privacy Policy · Terms of Use